ganirelics asetad (Q5521314)

UNII ^Saesneg

IX503L9WN0

14 Chwefror 2018

CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O

1 ffynhonnell

Dynodwr Drugbank (Alberta)

DrugBank ^Saesneg

06785

https://www.whocc.no/atc_ddd_index/?code=H01CC01

Saesneg

teitl

Ganirelix (Saesneg)

dyddiad cyhoeddi

17 Tachwedd 2015

defined daily dose ^Saesneg

0.25 milligram

dull gweini

parenteral route of administration ^Saesneg

1 ffynhonnell

cyfeirnod URL

clefyd a drinir

ovarian hyperstimulation syndrome ^Saesneg

1 ffynhonnell

NDF-RT ^Saesneg

NDF-RT

N0000148673

Saesneg

categori beichiogrwydd Unol Daleithiau America X

13 Rhagfyr 2016

categori beichiogrwydd

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

rôl y pwnc

hormone antagonist ^Saesneg

1 ffynhonnell

15 Mawrth 2018

C77423

1 ffynhonnell

UNII ^Saesneg

IX503L9WN0

InChI=1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1

14 Chwefror 2018

Identifiers

InChI

1 ffynhonnell

seiliwyd ar dybiaethau esboniadol

inferred from SMILES ^Saesneg

InChIKey ^Saesneg

GJNXBNATEDXMAK-PFLSVRRQSA-N

2 ffynonellau

Dynodwr Drugbank (Alberta)

DrugBank ^Saesneg

06785

Ganirelix (Saesneg)

17 Tachwedd 2015

UNII ^Saesneg

14 Chwefror 2018

1 ffynhonnell

UNII ^Saesneg

IX503L9WN0

GJNXBNATEDXMAK-PFLSVRRQSA-N

14 Chwefror 2018

ChemSpider ID ^Saesneg

1 ffynhonnell

PubChem CID ^Saesneg

1 ffynhonnell

1 ffynhonnell

matched by identifier from ^Saesneg

InChIKey ^Saesneg

ChEBI ID ^Saesneg

135910

mapping relation type ^Saesneg

exact match ^Saesneg

3 ffynonellau

ChEBI release 2019-10-02 ^Saesneg

InChI=1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1

ChEBI release 2021-03-01 ^Saesneg

matched by identifier from ^Saesneg

International Chemical Identifier ^Saesneg

InChI

ChEMBL ID ^Saesneg

CHEMBL1251

1 ffynhonnell

mewnforiwyd o

Wicipedia Saesneg

UniChem compound ID ^Saesneg

55513313

1 ffynhonnell

GJNXBNATEDXMAK-PFLSVRRQSA-N

UniChem ^Saesneg

DSSTox substance ID ^Saesneg

DTXSID401027283

1 ffynhonnell

matched by identifier from ^Saesneg

InChIKey ^Saesneg

EC number ^Saesneg

689-234-8

0 ffynonellau

ECHA Substance Infocard ID ^Saesneg

100.216.077

1 ffynhonnell

ECHA Substance Infocard database ^Saesneg

ECHA Substance Infocard ID ^Saesneg

100.216.077

27 Rhagfyr 2018

teitl

N-Acetyl-3-(2-naphthyl)-D-alanyl-p-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N 6-(N,N′-diethylamidino)-D-lysyl-L-leucyl-N 6-(N,N′-diethylamidino)-L-lysyl-L-prolyl-D-alaninamide (Saesneg)

dyfyniad

CAS no.: 124904-93-4 (Saesneg)

Cod yr ATC

H01CC01

1 ffynhonnell

Dynodwr Drugbank (Alberta)

DrugBank ^Saesneg

06785